The biotechnology services market was valued at USD 14.8 billion in 2024 and is expected to grow at a CAGR of 11.6% from 2025 to 2030. The demand for specialized services in biotechnology is increasing, driven by advancements in research and regulatory compliance.
Product Insights
Research support applications accounted for the largest market share in 2024, contributing 62.9% of total revenue, as companies seek external expertise for their R&D efforts. Regulatory compliance services are also gaining importance, reflecting the need for adherence to industry standards.
End-Use Insights
Biotech companies represented the largest end-users in 2024, holding a 66.4% market share, as they require specialized services for their development projects. Pharmaceutical companies are also increasingly utilizing biotechnology services to enhance their R&D capabilities.
Regional Insights
North America dominated the biotechnology services market with a 54.1% share in 2024, supported by a strong biotech ecosystem and extensive R&D activities. The Asia Pacific region is expected to grow rapidly, with a CAGR of 12.8%, as demand for biotechnology services increases.